: Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease

A simple test can detect the brain protein beta amyloid that is linked to the progression of Alzheimer’s disease.

Previous post : Nio’s stock rallies toward longest winning streak in more than 2 years
Next post Market Extra: The ‘narrow breadth’ chorus has fallen silent. What broadening participation in stock-market rally means for investors.